Your dose may increase as your treatment progresses, but your monthly cost remains consistent, removing financial barriers to reaching your optimal therapeutic dose
however, no significant differences in eGFR decline were identified in any of the treatment groups [44]
When chronically administered and slowly titrated, mCPP is actually protective and works as a partial serotonin agonist
The 2025 South Valley University meta-analysis found the same tradeoff: higher doses generally caused more weight loss, but they also increased the risk of side effects
You can recover monetary awards for intangible losses, including physical pain, mental anguish, emotional distress, loss of enjoyment, inconvenience, and diminished quality of life